Fecal Microbiota Transplant Protocol for Clostridium Difficile Infection

被引：20

作者：

Tauxe, William M. ^{[1
]}

Dhere, Tanvi ^{[2
]}

Ward, Angela ^{[2
]}

Racsa, Lori D. ^{[3
]}

Varkey, Jay B. ^{[4
]}

Kraft, Colleen S. ^{[3
,4
]}

机构：

[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA

[2] Emory Univ, Sch Med, Div Digest Dis, Atlanta, GA USA

[3] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA

[4] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA

来源：

LABMEDICINE | 2015年 / 46卷 / 01期

关键词：

FMT; fecal microbiota transplant; Clostridium difficile; CDI; stool;

D O I：

10.1309/LMCI95M0TWPDZKOD

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Fecal microbiota transplant has become more acceptable as a therapeutic for recurrent Clostridium difficile infection. The FDA has an enforcement discretion policy for practitioner's performing this therapy, which includes informed consent for this experimental treatment. This manuscript describes a typical procedure that can be followed that includes the important aspects of this preparation and treatment.

引用

页码：E19 / E23

页数：5

共 5 条

[1] Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].